Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rou-Hsin Wang"'
Autor:
Yu-Wei Lin, Hung-Cheng Su, Emmanuel Naveen Raj, Kuang-Kai Liu, Chien-Jen Chang, Tzu-Chia Hsu, Po-Yun Cheng, Rou-Hsin Wang, Yen-Her Lai, Chien-Hung Chen, Yen-Cheng Lin, Jui-I Chao
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 111 (2022)
Nanoprobes provide advantages for real-time monitoring of tumor markers and tumorigenesis during cancer progression and development. Epidermal growth factor receptor (EGFR) is a key protein that plays crucial roles for tumorigenesis and cancer therap
Externí odkaz:
https://doaj.org/article/174683a338e84a5788c13d3eecfa23ae
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 23:1309-1319
Background: Lung cancer has become one of the leading causes of cancer incidence and mortality worldwide. Non-small cell lung carcinoma (NSCLC) is the most common type among all lung cancer cases. NSCLC patients contained high levels of activating ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53f1f5ab599c557a9995690cb005f6d6
https://doi.org/10.2174/1871520623666230223111217
https://doi.org/10.2174/1871520623666230223111217
Autor:
Chien-I Lin, Zan-Chu Chen, Chien-Hung Chen, Yun-Hsuan Chang, Tsai-Chia Lee, Tsai-Tai Tang, Tzu-Wei Yu, Chih-Man Yang, Ming-Chang Tsai, Chi-Chou Huang, Tzu-Wei Yang, Chun-Che Lin, Rou-Hsin Wang, Guang-Yuh Chiou, Yuh-Jyh Jong, Jui-I Chao
Publikováno v:
Biochemical pharmacology. 206
Colorectal cancer (CRC) is a leading cause and mortality worldwide. Aurora A and haspin kinases act pivotal roles in mitotic progression. However, the blockage of Aurora A and Haspin for CRC therapy is still unclear. Here we show that the Haspin and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407aede5259fad1650fc0f9a41825d1d
https://pubmed.ncbi.nlm.nih.gov/36241092
https://pubmed.ncbi.nlm.nih.gov/36241092
Autor:
Yu-Chi Chan, Mei-Chih Liang, Chinpiao Chen, Chien-Jen Chang, Ya-Hui Wu, Pei-Ying Pan, Rou-Hsin Wang, Chih-Man Yang, Jinn-Moon Yang, Ya-Ping Hsu, Kuang-Kai Liu, Chien-Hung Chen, Su-Pei Wang, Kwok-Kin Wong, Jui-I Chao
Publikováno v:
Biochemical Pharmacology. 193:114792
Tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR-TKIs) are currently used therapy for non-small cell lung cancer (NSCLC) patients; however, drug resistance during cancer treatment is a critical problem. Survivin is an anti-apoptos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0954b4d456765feb08e1b155dc98ed4d
https://doi.org/10.1016/j.bcp.2021.114792
https://doi.org/10.1016/j.bcp.2021.114792